This study is testing a dietary supplement called Shengbai Oral Formula to see if it can help cancer patients undergoing chemotherapy. The formula contains 11 different herbs. Researchers want to know if it's safe and if it can reduce common side effects like fatigue, pain, and low white blood cell counts (neutropenia) during your third round of chemotherapy. You might be able to join if you are between 18 and 80 years old, have cancer, and are scheduled for at least three rounds of chemotherapy. The study will look at your fatigue levels after 14 days to see if the formula is helpful. The current status of this study is unclear.

Study design

This study plans to enroll 30 participants. It is an interventional study, meaning participants will receive a specific treatment.

What's involved

Participants will take either the Shengbai Oral Formula or an inactive placebo by mouth three times per day for 14 days. Fatigue will be measured at 14 days.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint, Brief Fatigue Inventory, is measured at 14 days.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.